Professional Associations that bring together competing entities, such as HL7, are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 activities, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust policy as stated in §05.01 of the Governance and Operations Manual (GOM).
Attendees
Goals
Discussion items
Time
Item
Who
Notes
10 min
Welcome, agenda review, meeting minute approval
Danny
No changes to the agenda
Minutes from last week's meeting were approved by consensus
Actively working through the unresolved issues (particularly terminology) and should be ready to schedule the next block vote shortly. Hoping to have all substantive changes done by the end of September, and proceed towards publication ASAP.
Longitudinal Maternal & Infant Health Information for Research IG
This is a May 2022 ballot, not sure why it is showing up here (will ask Lynn)
Project Insight Behind
NHSN Adverse Drug Event-Hypoglycemia Report
Sarah will look at closing the project
Longitudinal Maternal & Infant Health Information for Research
Vital Records Reporting Domain Analysis Model R4
AMS will update
HL7 Implementation Guide for CDA® Release 2: National Healthcare Safety Network (NHSN) Healthcare Associated Infection (HAI) Reports for Long Term Care Facilities (HAI-LTCF-CDA) and HL7 Implementation Guide for FHIR® Release 4: NHSN Healthcare Associated Infection (HAI) Reports for Long Term Care
Vital Records Mortality and Morbidity Reporting FHIR IG
AMS will update
SMART Health Cards: Vaccination & Testing Implementation Guide